In the midst of a court battle over whether to continue to allow access by mail to the medication abortion pill mifepristone, ...

Sen Ron Johnson's new report alleges Biden administration health officials ignored VAERS safety signals and suppressed COVID ...

Artificial intelligence shows promise for improving care for peripheral artery disease through earlier detection, improved ...

Councillors agree 'silent[ fireworks protocol v.1 ...

In this retrospective analysis, researchers used real-world data to investigate sex-associated differences in CAR T-cell therapy-related toxicity.

GLP-1RAs significantly reduce major cardiovascular events, mortality, and other clinically significant complications in ...

Community oncology teams partner with health systems to deliver advanced therapies safely, using hybrid dosing, toxicity ...

Q1 2026 Earnings Call May 11, 2026 8:00 PM EDTCompany ParticipantsRobert Rethy - Head of the Investor Relations & ...

Invivyd expects to advance VBY329 toward IND readiness in 2H 2026 for development in pediatric RSV prophylaxis, a blockbuster pharmaceutical market in 2024, expected to grow to $3-$4 billion in annual ...

Following a public consultation in 2022, the Medicines and Healthcare products Regulatory Agency (the "MHRA") and Health Research Authority ...

Perhaps no one should be surprised the report leaves a lot unsaid. The decision to have this report was a case of putting the ...